English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/123237
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Evaluation of chemically modified carrier proteins for developing monoclonal antibodies against a clinically relevant mutation of cKIT

AuthorsJara-Acevedo, Ricardo; González González, María; Jara-Acevedo, Maria; López-Pérez, Ricardo ; Orfao, Alberto ; Fuentes, Manuel
Issue Date2012
PublisherElsevier
CitationJournal of Immunological Methods 384(1-2): 171-176 (2012)
AbstractIn this report we show that combining double-chemically modified carrier proteins and hetero-functional cross-linkers allows preparing tailor-made hapten-protein carrier conjugates. Accordingly, a new carrier protein has been designed where carboxylic groups were transformed into highly reactive primary amino groups by reaction with ethylendiamine after activation with EDCI. The aminated protein carrier is then modified by different cross-linkers (hyper-activated proteins) at different conditions in order to control the conjugation ratio from 1 to > 12 molecules of hapten per carrier protein. Finally, this novel strategy has been successfully used to develop antibodies against a short specific peptide corresponding to a point mutation (D816V) of cKIT, which is a clinically relevant mutation related to mastocytosis and gastrointestinal stroma tumor. © 2012 Elsevier B.V.
Descriptionet al.
URIhttp://hdl.handle.net/10261/123237
DOI10.1016/j.jim.2012.07.007
Identifiersissn: 0022-1759
e-issn: 1872-7905
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.